---
title: "Fluvastatin - Arteriosclerotic Vascular Disease"
sidebar: mydoc_sidebar
permalink: db01095-mesh-d001161-1.html
toc: false 
---


Path ID: `DB01095_MESH_D001161_1`
{% include image.html url="images/db01095-mesh-d001161-1.png" file="db01095-mesh-d001161-1.png" alt="db01095-mesh-d001161-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C065180 | fluvastatin | Drug |
| UniProt:P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Protein |
| GO:0006695 | cholesterol biosynthetic process | BiologicalProcess |
| CHEBI:16113 | cholesterol | ChemicalSubstance |
| HP:0002621 | Atherosclerosis | PhenotypicFeature |
| MESH:D001161 | Arteriosclerotic vascular disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Fluvastatin | DECREASES ACTIVITY OF | 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase | POSITIVELY REGULATES | Cholesterol Biosynthetic Process |
| Cholesterol Biosynthetic Process | INCREASES ABUNDANCE OF | Cholesterol |
| Cholesterol | POSITIVELY CORRELATED WITH | Atherosclerosis |
| Atherosclerosis | MANIFESTATION OF | Arteriosclerotic Vascular Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01095](https://go.drugbank.com/drugs/DB01095)
  - [https://en.wikipedia.org/wiki/Fluvastatin#Mechanism_of_action](https://en.wikipedia.org/wiki/Fluvastatin#Mechanism_of_action)
